Product Name: Human CYR61 / CCN1 Antibody (Roche patent anti-CCN1, Research Use)
Catalog Number: NBR-0855
Target Name: CYR61 / CCN1
Trade Name: Roche patent anti-CCN1
Antibody Drug Description: The drug is a recombinant fully human anti-CCN1 monoclonal antibody, being developed by Roche. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name:  CCN1
Synonyms: CYR61; GIG1; IGFBP10
Target Description: Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion. Appears to play a role in wound healing by up-regulating, in skin fibroblasts, the expression of a number of genes involved in angiogenesis, inflammation and matrix remodeling including VEGA-A, VEGA-C, MMP1, MMP3, TIMP1, uPA, PAI-1 and integrins alpha-3 and alpha-5.
Ensembl:  ENSG00000142871
Uniprot:  O00622